The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

Long story short, there is a near-perfect correlation between consistent earnings growth and huge winners. On that note, here are three market-beating stocks that could turbocharge your returns.

CAVA (CAVA)

Return Since IPO: +50%

Starting from a single Washington, D.C. location, CAVA (NYSE: CAVA) operates a fast-casual restaurant chain offering customizable Mediterranean-inspired dishes.

Why Does CAVA Catch Our Eye?

1. Same-store sales growth over the past two years shows it’s successfully drawing diners into its restaurants
2. Earnings per share grew by 200% annually over the last one years and trumped its peers
3. Free cash flow margin jumped by 3.1 percentage points over the last year, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends

CAVA is trading at $65.69 per share, or 105.9x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.

United Therapeutics (UTHR)

Five-Year Return: +189%

Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ: UTHR) develops and commercializes medications for chronic lung diseases and other life-threatening conditions, with a focus on pulmonary hypertension treatments.

Why Is UTHR a Good Business?

1. Annual revenue growth of 20.7% over the last two years was superb and indicates its market share increased during this cycle
2. Strong free cash flow margin of 35.5% enables it to reinvest or return capital consistently, and its recently improved profitability means it has even more resources to invest or distribute
3. Returns on capital are growing as management capitalizes on its market opportunities

At $304 per share, United Therapeutics trades at 9.6x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

CBIZ (CBZ)

Five-Year Return: +168%

With over 120 offices across 33 states and a team of more than 6,700 professionals, CBIZ (NYSE: CBZ) provides accounting, tax, benefits, insurance brokerage, and advisory services to help small and mid-sized businesses manage their finances and operations.

Why Does CBZ Stand Out?

1. Annual revenue growth of 26.6% over the past two years was outstanding, reflecting market share gains this cycle
2. Projected revenue growth of 45.6% for the next 12 months is above its two-year trend, pointing to accelerating demand
3. Earnings growth has massively outpaced its peers over the last two years as its EPS has compounded at 29.6% annually

CBIZ’s stock price of $65.16 implies a valuation ratio of 16.9x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.

Stocks We Like Even More

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.